Erfordert Authentifizierung

The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells

   | 01. Dez. 2019

Zitieren

Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.10.1056/NEJM1998070233901029647873Search in Google Scholar

Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997;89:1533–42.Search in Google Scholar

Hulbert ML, Scothorn DJ, Panepinto JA, et al. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006;149:710–12.10.1016/j.jpeds.2006.06.03717095350Search in Google Scholar

Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369–73.10.1182/blood.V96.10.3369Search in Google Scholar

Wahl S, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion, 2012. In press.10.1111/j.1537-2995.2012.03659.x22519830Search in Google Scholar

Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007;47:2089–97.10.1111/j.1537-2995.2007.01434.x17958539Search in Google Scholar

Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.10.1046/j.1537-2995.2002.00126.x12147019Search in Google Scholar

Hoppe C, Klitz W, Vichinsky E, Styles L. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009;84:462–4.10.1002/ajh.2144219484735Search in Google Scholar

Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007;317:627–9.10.1126/science.114233117673654Search in Google Scholar

Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar

Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group [see comments]. N Engl J Med 1995;333:206–13.10.1056/NEJM1995072733304027791837Search in Google Scholar

Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar

Allen TI, Billingsley K, Slaughter J, et al. Red cell genotyping: a cost effective approach to screening large numbers of donors [abstract]. Transfusion 2009;49(Suppl):135A.Search in Google Scholar

Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J Jr, Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009;97:147–52.10.1111/j.1423-0410.2009.01185.x19392786Search in Google Scholar

Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381–8.10.1111/j.1537-2995.2011.03288.x21827505Search in Google Scholar

Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13–19.10.1111/j.1537-2995.2009.02382.x19778340Search in Google Scholar

Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004;44:67–72.10.1046/j.0041-1132.2003.00589.x14692969Search in Google Scholar

Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006;46:105–10.10.1111/j.1537-2995.2006.00679.x16398738Search in Google Scholar

Win N, New H, Lee E, de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008;48:1231–8.10.1111/j.1537-2995.2008.01693.x18373500Search in Google Scholar

Bachmeyer C, Maury J, Parrot A, et al. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol 2010;85:91–2.Search in Google Scholar

Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94–8.10.1046/j.1537-2995.1987.27187121485.x3810834Search in Google Scholar

Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.10.1111/j.1537-2995.2010.03045.x21332724Search in Google Scholar

Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190–3.10.5858/2005-129-190-PMODRB15679419Search in Google Scholar

Ambruso DR, Pallas C, Dickey W, et al. Prevention of alloimmunization in sickle cell disease: update on a successful and cost-effective regional program [abstract]. Presented at the 20th Meeting of the National Sickle Cell Disease Program. Boston, MA, March 18–21, 1995.Search in Google Scholar

eISSN:
1930-3955
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Laboratoriumsmedizin